Lyra Therapeutics Inc (NASDAQ:LYRA) has a beta value of -0.11 and has seen 1.24 million shares traded in the last trading session. The company, currently
Lyra Therapeutics Inc (NASDAQ:LYRA) has a beta value of -0.12 and has seen 1.1 million shares traded in the last trading session. The company, currently
During the last session, Lyra Therapeutics Inc (NASDAQ:LYRA)’s traded shares were 1.43 million, with the beta value of the company hitting -0.12. The 52-week high
During the last session, Lyra Therapeutics Inc (NASDAQ:LYRA)’s traded shares were 1.27 million, with the beta value of the company hitting -0.12. At the end
Lyra Therapeutics Inc (NASDAQ:LYRA)’s traded shares stood at 1.02 million during the last session, with the company’s beta value hitting -0.12. At the close of
In the last trading session, 1.62 million Lyra Therapeutics Inc (NASDAQ:LYRA) shares changed hands as the company’s beta touched -0.12. With the company’s per share
In last trading session, Lyra Therapeutics Inc (NASDAQ:LYRA) saw 1.34 million shares changing hands with its beta currently measuring -0.13. Company’s recent per share price
Lyra Therapeutics Inc (NASDAQ:LYRA) has a beta value of -0.12 and has seen 1.27 million shares traded in the last trading session. The company, currently
Lyra Therapeutics Inc (NASDAQ:LYRA) has a beta value of -0.12 and has seen 1.03 million shares traded in the last trading session. The LYRA stock
During the recent session, Lyra Therapeutics Inc (NASDAQ:LYRA)’s traded shares were 0.94 million, with the beta value of the company hitting -0.11. At the last
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
